The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Relapse in schizophrenia: costs, clinical outcomes and quality of life
Open accessAbstract
Background: Relapse is one of the most costly aspects of schizophrenia. Aims: To compare costs, clinical outcomes and quality of life for patients who experienced relapse in schizophrenia with a control group who did not relapse. Method: Patients were randomly selected from current psychiatric case-loads drawn from urban and suburban areas of Leicester. Differences in costs and outcomes by relapse status in the previous 6 months were examined using parametric and non-parametric tests, and multivariate analysis was used to examine factors associated with relapse and costs. Results: Costs for the patients who relapsed were over four times higher than those for the non-relapse group. There were few statistically significant differences in clinical and quality of life measures by relapse status. Multivariate analyses suggested some significant correlates of relapse and costs. Conclusions: The higher costs associated with relapse will be of interest to policy-makers who face difficult choices concerning new but more expensive treatments for patients with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(1976) · Medical Entomology and Zoology · Cited by 8,899
Quality of life and pharmacoeconomics in clinical trials
Pater, J. (1996) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)82191-5 · Cited by 2,395
Quality of life and pharmacoeconomics in clinical trials
Spilker, B. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,862
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_300379 · Cited by 1,445
Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.241 · Cited by 1,327
Costing psychiatric interventions.
Beecham, J. K., & Knapp, M. R. J. (1992) · Kent Academic Repository (University of Kent) · Cited by 710
Self-citationSlade, M., & Thornicroft, G. (2025) · Oxford Textbook of Community Mental Health · doi:10.1093/med/9780198898818.003.0007 · Cited by 679
Cost of Relapse in Schizophrenia
Weiden, P. J., & Olfson, M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.419 · Cited by 666
Cited by
Alvarez-Jimenez, M., Priede, A., Hetrick, S. E., Bendall, S., Killackey, E., Parker, A. G., McGorry, P. D., & Gleeson, J. F. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.007 · Cited by 511
Expressed Emotion and Relapse of Psychopathology
Hooley, J. M. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095236 · Cited by 499
Relapse prediction in schizophrenia through digital phenotyping: a pilot study
Barnett, I., Torous, J., Staples, P., Sandoval, L., Keshavan, M., & Onnela, J.-P. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0030-z · Cited by 422
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314540297 · Cited by 297
(2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.7090su1cj · Cited by 282
Cost-of-Illness Studies: A Review of Current Methods
Akobundu, E., Ju, J., Blatt, L., & Mullins, C. D. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624090-00005 · Cited by 279
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X., & Conley, R. R. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-2 · Cited by 275
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-32 · Cited by 270
Cohen, A., Naslund, J. A., Chang, S., Nagendra, S., Bhan, A., Rozatkar, A., Thirthalli, J., Bondre, A., Tugnawat, D., Reddy, P. V., et al. (2023) · Schizophrenia · doi:10.1038/s41537-023-00332-5 · Cited by 90
Eisner, E., Drake, R. J., Berry, N., Barrowclough, C., Emsley, R., Machin, M., & Bucci, S. (2019) · JMIR mHealth and uHealth · doi:10.2196/11568 · Cited by 73
Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30024-8 · Cited by 60
Kotzeva, A., Mittal, D., Desai, S., Judge, D., & Samanta, K. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2022.2157596 · Cited by 57
Meyer, N., Kerz, M., Folarin, A., Joyce, D. W., Jackson, R., Karr, C., Dobson, R., & MacCabe, J. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.8292 · Cited by 58
Fikreyesus, M., Soboka, M., & Feyissa, G. T. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1076-2 · Cited by 48
Emsley, R., Asmal, L., Rubio, J. M., Correll, C. U., & Kane, J. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.025 · Cited by 41
Sigrunarson, V., Moljord, I. E. O., Steinsbekk, A., Eriksen, L., & Morken, G. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1240231 · Cited by 31
Socio–economic correlates of relapsed patients admitted in a Nigerian mental health institution
Gbiri, C. A., Badru, F. A., Ladapo, H. T. O., & Gbiri, A. A. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.506954 · Cited by 20
Aigbogun, M. S., Liu, S., Kamat, S. A., Sapin, C., Duhig, A. M., & Citrome, L. (2018) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s160252 · Cited by 18
Metadata
- Authors
- Almond, S., Knapp, M., Francois, C., Toumi, M., & Brugha, T.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2004-04
- Volume
- 184
- Issue
- 4
- Pages
- 346-351
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2123785744
- Cited by
- 310
- References
- 23
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.